Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX‐770 (ivacaftor)

BACKGROUND AND PURPOSE: The most common cystic fibrosis (CF) mutation F508del inhibits the gating and surface expression of CFTR, a plasma membrane anion channel. Optimal pharmacotherapies will probably require both a ‘potentiator’ to increase channel open probability and a ‘corrector’ that improves...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: Matthes, Elizabeth, Goepp, Julie, Carlile, Graeme W, Luo, Yishan, Dejgaard, Kurt, Billet, Arnaud, Robert, Renaud, Thomas, David Y, Hanrahan, John W
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728415/
https://ncbi.nlm.nih.gov/pubmed/26492939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados